Efficacy and side-effects of two praziquantel treatments against Schistosoma haematobium infection, among schoolchildren from Côte d'Ivoire

References

• Appleton, C. C. & Mbaye, A. (2001). Praziquantel — quality, dosages and markers of resistance. Trends in Parasitology, 17, 356–357.
   PubMedGoogle Scholar
• Bergquist, N. R. (2002). Schistosomiasis: from risk assessment to control. Trends in Parasitology, 18, 309–314.
   PubMed Web of Science ®Google Scholar
• Berhe, N., Gundersen, S. G., Abebe, F., Birrie, H., Medhin, G. & Gemetchu, T. (1999). Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north—east Ethiopia. Acta Tropica, 72, 53–63.
   PubMed Web of Science ®Google Scholar
• Borrmann, S., Szlezhk, N., Faucher, J.-F., Matsiegui, P.-B., Neubauer, R., Binder, R. K., Lell, B. & Kremsner, P. G. (2001). Artesunate and praziquantel for the treatment of Schistosoma haematobium infections: a double-blind, randomized, placebo-controlled study. Journal of Infectious Diseases, 184, 1363–1366.
   Google Scholar
• Cioli, D. (1998). Chemotherapy of schistosomiasis: an update. Parasitology Today, 14, 418–422.
   PubMedGoogle Scholar
• Cioli, D. (2000). Praziquantel: is there real resistance and are there alternatives? Current Opinion in Infectious Diseases, 13, 659–663.
   PubMed Web of Science ®Google Scholar
• Cioli, D., Pica-Mattoccia, L. & Archer, S. (1995). Antischistosomal drugs: past, present ... and future? Pharmacology and Therapeutics, 68, 35–85.
   PubMed Web of Science ®Google Scholar
• Danso-Appiah, A. & de Vlas, S. J. (2002). Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal. Trends in Parasitology, 18, 125–129.
   PubMed Web of Science ®Google Scholar
• Davis, A. & Wegner, D. H. (1979). Multicentre trials of praziquantel in human schistosomiasis: design and techniques. Bulletin of the World Health Organization, 57, 767–771.
   PubMed Web of Science ®Google Scholar
• De Clercq, D., Vercruysse, J., Verle, P., Kongs, A. & Diop, M. (2000). What is the effect of combining artesunate and praziquantel in the treatment of Schistosoma mansoni infections? Tropical Medicine and International Health, 5, 744–746.
   PubMed Web of Science ®Google Scholar
• De Clercq, D., Vercruysse, J., Kongs, A., Verle, P., Dompnier, J. P. & Faye, P. C. (2002). Efficacy of artesunate and praziquantel in Schistosoma haemato-bium infected schoolchildren. Acta Tropica, 82, 61–66.
   PubMed Web of Science ®Google Scholar
• Doenhoff, M., Kimani, G. & Cioli, D. (2000). Praziquantel and the control of schistosomiasis. Parasitology Today, 16, 364–366.
   PubMedGoogle Scholar
• Engels, D., Chitsulo, L., Montresor, A. & Savioli, L. (2002). The global epidemiological situation of schistosomiasis and new approaches to control and research. Acta Tropica, 82, 139–146.
   PubMed Web of Science ®Google Scholar
• Garba, A., Tohon, Z., Sidiki, A., Chippaux, J.-P. & de Chabalier, F. (2001). Efficacite et tolerance du praziquantel chez l'enfant d'fige scolaire en zone hyper-endemique a Schistosoma haematobium (Niger, 1999). Bulletin de la Societe de Pathologie Exotique, 94, 42–45.
   PubMedGoogle Scholar
• Gönnert, R. & Andrews, P. (1977). Praziquantel, a new broad-spectrum antischistosomal agent. Zeitschrift far Parasitenkunde, 52, 129–150.
   PubMed Web of Science ®Google Scholar
• Groll, E. (1984). Praziquantel. Advances in Pharmacology and Chemotherapy, 20, 219–238.
   PubMedGoogle Scholar
• Gryseels, B., Mbaye, A., De Vlas, S. J., Stelma, F. F., Guisse, F., van Lieshout, L., Faye, D., Diop, M., Ly, A., Tchuem-Tchuenté, L. A., Engels, D. & Polman, K. (2001). Are poor responses to prazi-quantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance? An overview of the evidence. Tropical Medicine and International Health, 6, 864–873.
   PubMed Web of Science ®Google Scholar
• Guissé, F., Polman, K., Stelma, F. F., Mbaye, A., Talla, I., Niang, M., Deelder, A. M., Ndir, O. & Gryseels, B. (1997). Therapeutic evaluation of two different dose regimens of praziquantel in a recent Schistosoma mansoni focus in northern Senegal. American Journal of Tropical Medicine and Hygiene, 56, 511–514.
   PubMed Web of Science ®Google Scholar
• Ismail, M., Metwally, A., Farghaly, A., Bruce, J., Tao, L. F. & Bennett, J. L. (1996). Characterisation of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. American Journal of Tropical Medicine and Hygiene, 55, 214–218.
   PubMed Web of Science ®Google Scholar
• Ismail, M., Botros, S., Metwally, A., William, S., Farghally, A., Tao, L. F., Day, T. A. & Bennett, J. L. (1999). Resistance to praziquantel: direct evidence from Schistosoma mansoni isolated from Egyptian villagers. American Journal of Tropical Medicine and Hygiene, 60, 932–935.
   PubMed Web of Science ®Google Scholar
• James, C., Webbe, G. & Nelson, G. S. (1977). The susceptibility to praziquantel of Schistosoma haematobium in the baboon (Papio anubis) and of S. japonicurn in the vervet monkey (Cercopithecus aethiops). Zeitschrift far Parasitenkunde, 52, 179–194.
   Google Scholar
• Kahama, A. I., Vennervald, B. J., Kombe, Y., Kihara, R. W., Ndzovu, M., Mungai, P. & Ouma, J. H. (1999). Parameters associated with Schistosoma haematobium infection before and after chemotherapy in school children from two villages in the Coast province of Kenya. Tropical Medicine and International Health, 4, 335–340.
   PubMed Web of Science ®Google Scholar
• King, C. H., Muchiri, E. M. & Ouma, J. H. (2000). Evidence against rapid emergence of praziquantel resistance in Schistosoma haematobium, Kenya. Emerging Infectious Diseases, 6, 585–594.
   PubMed Web of Science ®Google Scholar
• Kusel, J. & Hagan, P. (1999). Praziquantel - its use, cost and possible development of resistance. Parasitology Today, 15, 352–354.
   PubMedGoogle Scholar
• Massoud, A. A. E., El Kholy, A. M. & Anwar, W. A. (1984). Assessment of efficacy of praziquantel against Schistosoma mansoni infection. Journal of Tropical Medicine and Hygiene, 87,119–121.
   PubMedGoogle Scholar
• N'Goran, E. K., Diabate, S., Utzinger, J. & Sellin, B. (1997). Changes in human schistosomiasis levels after the construction of two large hydroelectric dams in central Cote d'Ivoire. Bulletin of the World Health Organization, 75,541–545.
   PubMed Web of Science ®Google Scholar
• N'Goran, E. K., Utzinger, J., N'Guessan, A. N., Muller, I., Zamble, K., Lohourignon, K. L., Traore, M., Sosthene, B. A., Lengeler, C. & Tanner, M. (2001). Reinfection with Schistosoma haematobium following school-based chemotherapy with praziquantel in four highly endemic villages in Côte d'Ivoire. Tropical Medicine and International Health, 6, 817–825.
   PubMed Web of Science ®Google Scholar
• N'Goran, E. K., Utzinger, J., Gnaka, H. N., Yapi, A., N'Guessan, N. A., Kigbafori, S. D., Lengeler, C., Chollet, J., Xiao, S. H. & Tanner, M. (2003). Randomized, double-blind, placebo-controlled trial of oral artemether for the prevention of patent Schistosoma haematobium infections. American Journal of Tropical Medicine and Hygiene, 68, 24–32.
   PubMed Web of Science ®Google Scholar
• Ofoezie, I. E. (2000). Patterns of reinfection following praziquantel treatment of urinary schistosomiasis at a period of low transmission. Acta Tropica, 75, 123–126.
   PubMed Web of Science ®Google Scholar
• Olds, G. R., King, C., Hewlett, J., Olveda, R., Wu, G., Ouma, J., Peters, P., McGarvey, S., Odhiambo, O., Koech, D., Liu, C. Y., Aligui, G., Gachihi, G., Kombe, Y., Parraga, I., Ramirez, B., Whalen, C., Horton, R. J. & Reeve, P. (1999). Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths. Journal of Infectious Diseases, 179, 996–1003.
   PubMed Web of Science ®Google Scholar
• Picquet, M., Vercruysse, J., Shaw, D. J., Diop, M. & Ly, A. (1998). Efficacy of praziquantel against Schistosoma mansoni in northern Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene, 92, 90–93.
   PubMed Web of Science ®Google Scholar
• Plouvier, S., Leroy, J.-C. & Colette, J. (1975). A propos d'une technique simple de filtration des urines dans le diagnostic de la bilharziose urinaire en enquete de masse. Médecine Tropicale, 35, 229–230.
   Google Scholar
• Renganathan, E. & Cioli, D. (1998). An international initiative on praziquantel use. Parasitology Today, 14, 390–391.
   PubMedGoogle Scholar
• Sabah, A. A., Fletcher, C., Webbe, G. & Doenhoff, M. J. (1986). Schistosoma mansoni: chemotherapy of infections of different ages. Experimental Parasitology, 61, 294–303.
   PubMed Web of Science ®Google Scholar
• Seubert, J., Pohlke, R. & Loebich, F. (1977). Synthesis and properties of praziquantel, a novel broad spectrum anthelmintic with excellent activity against schistosomes and cestodes. Experientia, 33, 1036–1037.
   PubMedGoogle Scholar
• Shaw, D. J., Vercruysse, J., Picquet, M., Sambou, B. & Ly, A. (1999). The effect of different treatment regimens on the epidemiology of seasonally trans-mitted Schistosoma haematobium infections in four villages in the Senegal River Basin, Senegal. Transactions of the Royal Society of Tropical Medicine and Hygiene, 93, 142–150.
   PubMed Web of Science ®Google Scholar
• Stelma, F. F., Sall, S., Daff, B., Sow, S., Niang, M. & Gryseels, B. (1997). Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low. Journal of Infectious Diseases, 176, 304–307.
   PubMed Web of Science ®Google Scholar
• Thomas, H. & Gönnert, R. (1977). The efficacy of praziquantel against cestodes in animals. Zeitschrift far Parasitenkunde, 52,117–127.
   Google Scholar
• Utzinger, J., N'Goran, E. K., N'Dri, A., Lengeler, C. & Tanner, M. (2000). Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection. Tropical Medicine and International Health, 5,771–778.
   PubMed Web of Science ®Google Scholar
• Utzinger, J., Chollet, J., You, J. Q., Mei, J. Y., Tanner, M. & Xiao, S. H. (2001a). Effect of com-bined treatment with praziquantel and artemether on Schistosoma japonicum and Schistosoma mansoni in experimentally infected animals. Aaa Tropica, 80, 9–18.
   PubMed Web of Science ®Google Scholar
• Utzinger, J., Xiao, S. H., N'Goran, E. K., Bergquist, R. & Tanner, M. (2001b). The potential of artemether for the control of schistosomiasis. International Journal for Parasitology, 31, 1549–1562.
   PubMed Web of Science ®Google Scholar
• Van Etten, L., Kremsner, P. G., Krijger, F. W. & Deelder, A. M. (1997). Day-to-day variation of egg output and schistosome circulating antigens in urine of Schistosoma haematobium-infected school children from Gabon and follow-up after chemotherapy. American Journal of Tropical Medicine and Hygiene, 57,337–341.
   PubMed Web of Science ®Google Scholar
• Van Lieshout, L., Stelma, F. F., Guisse, F., Falcao Ferreira, S. T., Polman, K., van Dam, G. J., Diakhate, M., Sow, S., Deelder, A. & Gryseels, B. (1999). The contribution of host-related factors to low cure rates of praziquantel for the treatment of Schistosoma mansoni in Senegal. American Journal of Tropical Medicine and Hygiene, 61, 760–765.
   PubMed Web of Science ®Google Scholar
• Webbe, G. & James, C. (1977). A comparison of the susceptibility to praziquantel of Schistosoma haemato-bium, S. japonicum, S. mansoni, S. intercalatum and S. mattheei in hamsters. Zeitschrift far Parasitenkunde, 52,169–177.
   Google Scholar
• Wegner, D. H. G. (1984). The profile of the tremato-dicidal compound praziquantel. Arzneimitte,orschung, 34, 1132–1136.
   PubMed Web of Science ®Google Scholar
• William, S., Botros, S., Ismail, M., Farghally, A., Day, T. A. & Bennett, J. L. (2001a). Praziquantel-induced tegumental damage in vitro is diminished in schistosomes derived from praziquantel-resistant infections. Parasitology, 122, 63–66.
   PubMed Web of Science ®Google Scholar
• William, S., Sabra, A., Ramzy, F., Mousa, M., Demerdash, Z., Bennett, J. L., Day, T. A. & Botros, S. (2001 b). Stability and reproductive fitness of Schistosoma mansoni isolates with decreased sensitivity to praziquantel. International Journal for Parasitology, 31, 1093–1100.
   PubMed Web of Science ®Google Scholar
• Wilkins, H. A. & Moore, P. J. (1987). Comparative trials of regimes for the treatment of urinary schisto-somiasis in The Gambia. Journal of Tropical Medicine and Hygiene, 90, 83–92.
   PubMed Web of Science ®Google Scholar
• Xiao, S. H., Catto, B. A. & Webster, L. T. (1985). Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo. Journal of Infectious Diseases, 151, 1130–1137.
   PubMed Web of Science ®Google Scholar
• Xiao, S. H., Utzinger, J., Chollet, J., Endriss, Y., N'Goran, E. K. & Tanner, M. (2000). Effect of artemether against Schistosoma haematobium in experi-mentally infected hamsters. International Journal for Parasitology, 30, 1001–1006.
   PubMed Web of Science ®Google Scholar
• Xiao, S. H., Tanner, M., N'Goran, E. K., Utzinger, J., Chollet, J., Bergquist, R., Chen, M. G. & Zeng, J. (2002). Recent investigations of artemether, a novel agent for the prevention of schistosomiasis japonica, mansoni and haematobia. Acta Tropica, 82, 175–181.
   PubMed Web of Science ®Google Scholar